Cargando…

EVI1 Promotes the Proliferation and Invasive Properties of Human Head and Neck Squamous Cell Carcinoma Cells

Head and neck squamous cell carcinoma (HNSCC) is a frequent malignancy with a poor prognosis. So far, the EGFR inhibitor cetuximab is the only approved targeted therapy. A deeper understanding of the molecular and genetic basis of HNSCC is needed to identify additional targets for rationally designe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grandits, Alexander Michael, Bromberger, Sophie, Heller, Gerwin, Reinoehl, Barbara Andrea, Tomasich, Erwin, Schossleitner, Klaudia, Berghoff, Anna Sophie, Fuereder, Thorsten, Wieser, Rotraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835242/ https://www.ncbi.nlm.nih.gov/pubmed/35162973 http://dx.doi.org/10.3390/ijms23031050

Ejemplares similares

Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/Npm1c-Driven Acute Myeloid Leukemia Cells
por: Nguyen, Chi Huu, et al.
Publicado: (2020)

DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma
por: Starzer, Angelika Martina, et al.
Publicado: (2022)

EVI1 promotes tumor growth via transcriptional repression of MS4A3
por: Heller, Gerwin, et al.
Publicado: (2015)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease
por: Wieser, Rotraud
Publicado: (2012)

Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes
por: Konrad, Torsten A., et al.
Publicado: (2009)

Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A
por: Grandits, Alexander M., et al.
Publicado: (2021)

The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid
por: Steinmetz, Birgit, et al.
Publicado: (2014)

Phosphorylated cingulin localises GEF-H1 at tight junctions to protect vascular barriers in blood endothelial cells
por: Holzner, Silvio, et al.
Publicado: (2021)

All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells
por: Nguyen, Chi H., et al.
Publicado: (2020)

Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness
por: Grandits, Alexander Michael, et al.
Publicado: (2021)

DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case–Control Study
por: Millesi, Matthias, et al.
Publicado: (2022)

RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks
por: Kellaway, Sophie G., et al.
Publicado: (2020)

Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation
por: Chan, Lai-Sheung, et al.
Publicado: (2020)

All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia
por: Nguyen, Chi Huu, et al.
Publicado: (2019)

EVI1 Inhibits Apoptosis Induced by Antileukemic Drugs via Upregulation of CDKN1A/p21/WAF in Human Myeloid Cells
por: Rommer, Anna, et al.
Publicado: (2013)

CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia
por: Gluexam, Tobias, et al.
Publicado: (2019)

MALAT1 Fusions and Basal Cells Contribute to Primary Resistance against Androgen Receptor Inhibition in TRAMP Mice
por: Marhold, Maximilian, et al.
Publicado: (2022)

SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness
por: Nguyen, Chi Huu, et al.
Publicado: (2019)

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia
por: Tanaka, Atsushi, et al.
Publicado: (2022)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
por: Leblanc, Olivia, et al.
Publicado: (2020)

Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck
por: Guenne, Clémence, et al.
Publicado: (2014)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
por: Gurudutt, Vivek V., et al.
Publicado: (2011)

Hypoxia in Head and Neck Squamous Cell Carcinoma
por: Li, John Zenghong, et al.
Publicado: (2012)

Immunotherapy for Head and Neck Squamous Cell Carcinoma
por: Moskovitz, Jessica, et al.
Publicado: (2018)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
por: Flach, Susanne, et al.
Publicado: (2022)

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
por: Harrington, Kevin J., et al.
Publicado: (2023)

Addictions, Social Deprivation and Cessation Failure in Head and Neck Squamous Cell Carcinoma Survivors
por: Nokovitch, Lara, et al.
Publicado: (2023)

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
por: Cai, Tingting, et al.
Publicado: (2020)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
por: Monroe, Marcus M., et al.
Publicado: (2011)

Cancer stem cells in head and neck squamous cell carcinoma
por: Karamboulas, Christina, et al.
Publicado: (2013)

Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma
por: Qi, Zongtai, et al.
Publicado: (2021)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma
por: Kumar, Harish A., et al.
Publicado: (2023)

Microsatellite instability in squamous cell carcinoma of the head and neck.
por: Field, J. K., et al.
Publicado: (1995)

Docetaxel in the treatment of squamous cell carcinoma of the head and neck
por: Rapidis, Alexander, et al.
Publicado: (2008)

Mononuclear phagocytes in head and neck squamous cell carcinoma
por: Kross, Kenneth Wilfried, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8ihiso5n0k7n3rpkurma0reefu